ADN1.DEADN1.DEXETRA
Loading
EBITDA Margin Over TimeStable
Percentile Rank50
3Y CAGR-19.8%
5Y CAGR-6.2%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-19.8%/yr
vs +17.7%/yr prior
5Y CAGR
-6.2%/yr
Recent deceleration
Acceleration
-37.6pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
20247.82%+7.8%
20237.26%-30.0%
202210.37%-31.7%
202115.18%+31.4%
202011.56%+7.5%
201910.75%+22.4%
20188.78%+11.2%
20177.90%-12.3%
20169.01%+20.9%
20157.45%-